These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18495217)

  • 1. Evaluation of a new commercial dilute prothrombin time in the diagnosis of lupus anticoagulants.
    Devreese KM
    Thromb Res; 2008; 123(2):404-11. PubMed ID: 18495217
    [No Abstract]   [Full Text] [Related]  

  • 2. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rebuttal to: strong lupus anticoagulant can influence the prothrombin time INR falsifying the follow up of oral anticoagulation.
    Bailleul E; Van Vaerenbergh K; Lust A
    Thromb Haemost; 2005 Sep; 94(3):687; author reply 688. PubMed ID: 16268495
    [No Abstract]   [Full Text] [Related]  

  • 4. Testing strategies for diagnosing lupus anticoagulant: decision analysis.
    Segal JB; Lehmann HP; Petri M; Mueller L; Kickler TS
    Am J Hematol; 2002 Jul; 70(3):195-205. PubMed ID: 12111765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of phospholipid on the detection of lupus anticoagulants by the dilute Russell viper venom time.
    Brandt JT; Triplett DA
    Arch Pathol Lab Med; 1989 Dec; 113(12):1376-8. PubMed ID: 2511818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dilute Russell's viper venom time.
    Radhakrishnan K
    Methods Mol Biol; 2013; 992():341-8. PubMed ID: 23546726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired activated protein C-resistance in patients with lupus anticoagulants.
    Ehrenforth S; Radtke KP; Scharrer I
    Thromb Haemost; 1995 Aug; 74(2):797-8. PubMed ID: 8585027
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of a new silica clotting time in the diagnosis of lupus anticoagulants.
    Devreese KM
    Thromb Res; 2007; 120(3):427-38. PubMed ID: 17156825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lupus anticoagulants.
    Shapiro SS; Thiagarajan P
    Prog Hemost Thromb; 1982; 6():263-85. PubMed ID: 6820164
    [No Abstract]   [Full Text] [Related]  

  • 10. Lupus anticoagulants in children.
    Singh AK; Rao KP; Kizer J; Lazarchick J
    Ann Clin Lab Sci; 1988; 18(5):384-7. PubMed ID: 3140708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory identification of lupus anticoagulants using the combination of activated partial thromboplastin time and Russell's viper venom at two phospholipid concentrations.
    Akkawat B; Chantarangkul V; Rojnuckarin P; Juntiang J
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S451-8. PubMed ID: 12930024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied.
    Moore GW; Savidge GF
    Thromb Res; 2006; 118(4):523-8. PubMed ID: 16263154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of a platelet neutralization procedure with a hexagonal phase phospholipid neutralization assay as confirmatory tests for the presence of lupus anticoagulants.
    Reber G; Roisin JP; Migaud M; de Moerloose P
    Thromb Res; 1994 Jan; 73(2):131-5. PubMed ID: 8171412
    [No Abstract]   [Full Text] [Related]  

  • 14. Non-parallelism in the one-stage coagulation factor assay is a phenomenon of lupus anticoagulants and not of individual factor inhibitors.
    Ruinemans-Koerts J; Peterse-Stienissen I; Verbruggen B
    Thromb Haemost; 2010 Nov; 104(5):1080-2. PubMed ID: 20806127
    [No Abstract]   [Full Text] [Related]  

  • 15. A simplified algorithm for the laboratory detection of lupus anticoagulants: utilization of two automated integrated tests.
    Zhang L; Whitis JG; Embry MB; Hollensead SC
    Am J Clin Pathol; 2005 Dec; 124(6):894-901. PubMed ID: 16416739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring oral anticoagulation in patients with "strong" lupus anticoagulant. Present situation in France.
    Goudemand J; Boffa MC
    Ann Med Interne (Paris); 1996 Sep; 147 Suppl 1():36-7. PubMed ID: 8952759
    [No Abstract]   [Full Text] [Related]  

  • 17. Coagulation profile in systemic lupus erythematosus studies in 20 patients.
    Boey ML; Tsakok FH; Feng PH
    Singapore Med J; 1985; 26(4-5):361-4. PubMed ID: 4071090
    [No Abstract]   [Full Text] [Related]  

  • 18. [The lupus inhibitor].
    Carreras LO; Vermylen J
    Sangre (Barc); 1981; 26(5-A):610-8. PubMed ID: 6798699
    [No Abstract]   [Full Text] [Related]  

  • 19. Lupus anticoagulant-hypoprothrombinemia syndrome associated with systemic lupus erythematosus: report of 2 cases and review of literature.
    Erkan D; Bateman H; Lockshin MD
    Lupus; 1999; 8(7):560-4. PubMed ID: 10483036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged activated partial thromboplastin times and detection of the lupus anticoagulant.
    Lucas FV; Miller ML
    Arch Pathol Lab Med; 1993 Jun; 117(6):589-90. PubMed ID: 8503727
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.